平安证券:创新药BD大单频现,投资机会凸显

财中社
Aug 04

8月4日,平安证券发布生物医药行业研报称,国内BD持续落地。2025年下半年以来国内创新药BD项目持续落地。本周初,恒瑞医药宣布与GSK达成重磅合作协议:恒瑞将呼吸管线核心品种HRS-9821及11个早期项目的全球权益(不含中国内地及港澳台)授权给GSK,交易包含5亿美元首付款、潜在120亿美元里程碑付款及销售分成。随后,石药集团于2025年7月30日宣布,已与...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10